Prevalence of Plasmodium falciparum isolates lacking the histidine rich protein 2 gene among symptomatic malaria patients in Kwilu Province of the Democratic Republic of Congo.
False negative
Gene deletion
Plasmodium falciparum histidine rich protein 2
Rapid diagnostic test
Symptomatic patient
Journal
Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645
Informations de publication
Date de publication:
25 May 2021
25 May 2021
Historique:
received:
22
01
2021
accepted:
13
05
2021
entrez:
26
5
2021
pubmed:
27
5
2021
medline:
26
11
2021
Statut:
epublish
Résumé
Malaria rapid diagnostic tests have become a primary and critical tool for malaria diagnosis in malaria-endemic countries where Plasmodium falciparum Histidine Rich Protein 2-based rapid diagnostic tests (PfHRP2-based RDTs) are widely used. However, in the last decade, the accuracy of PfHRP2-based RDTs has been challenged by the emergence of P. falciparum strains harbouring deletions of the P. falciparum histidine rich protein 2 (pfhrp2) gene, resulting in false-negative results. In the Democratic Republic of Congo (D.R. Congo), little is known about the prevalence of the pfhrp2 gene deletion among P. falciparum isolates infecting symptomatic patients, especially in low to moderate transmission areas where pfhrp2 deletion parasites are assumed to emerge and spread. Here we determine the local prevalence and factors associated with pfhrp2 gene deletions among symptomatic malaria patients in the Kwilu Province of the D.R. Congo. We used secondary data from a prospective health facility-based cross-sectional study conducted in 2018. Blood was collected for microscopy, PfHRP2-RDT, and spotted onto Whatman filter paper for downstream genetic analysis. Genomic DNA was extracted and used to perform PCR assays for the detection and confirmation of pfhrp2 gene deletions. Fischer's exact and the Kruskal-Wallis tests were applied to look for associations between potential explanatory variables and the pfhrp2 gene deletion with a level of statistical significance set at P < 0.05. Of the 684 enrolled symptomatic patients, 391 (57.7%) were female. The majority (87.7%) reported the presence of mosquito breeding sites within the household's compound, and fever was the most reported symptom (81.6%). The overall prevalence of the pfhrp2 gene deletion was 9.2% (95% CI: 6.7%-12.1%). The deletion of the pfhrp2 gene was associated with health zone of origin (P = 0.012) and age (P = 0.019). Among false-negative PfHRP2-RDT results, only 9.9% were due to pfhrp2 gene deletion. P. falciparum isolates with pfhrp2 gene deletions are relatively common among symptomatic patients in Kwilu province. Further investigations are needed to provide enough evidence for policy change. Meanwhile, the use of RDTs targeting PfHRP2 and parasite lactate dehydrogenase (pLDH) antigens could limit the spread of deleted isolates.
Sections du résumé
BACKGROUND
BACKGROUND
Malaria rapid diagnostic tests have become a primary and critical tool for malaria diagnosis in malaria-endemic countries where Plasmodium falciparum Histidine Rich Protein 2-based rapid diagnostic tests (PfHRP2-based RDTs) are widely used. However, in the last decade, the accuracy of PfHRP2-based RDTs has been challenged by the emergence of P. falciparum strains harbouring deletions of the P. falciparum histidine rich protein 2 (pfhrp2) gene, resulting in false-negative results. In the Democratic Republic of Congo (D.R. Congo), little is known about the prevalence of the pfhrp2 gene deletion among P. falciparum isolates infecting symptomatic patients, especially in low to moderate transmission areas where pfhrp2 deletion parasites are assumed to emerge and spread. Here we determine the local prevalence and factors associated with pfhrp2 gene deletions among symptomatic malaria patients in the Kwilu Province of the D.R. Congo.
METHODS
METHODS
We used secondary data from a prospective health facility-based cross-sectional study conducted in 2018. Blood was collected for microscopy, PfHRP2-RDT, and spotted onto Whatman filter paper for downstream genetic analysis. Genomic DNA was extracted and used to perform PCR assays for the detection and confirmation of pfhrp2 gene deletions. Fischer's exact and the Kruskal-Wallis tests were applied to look for associations between potential explanatory variables and the pfhrp2 gene deletion with a level of statistical significance set at P < 0.05.
RESULTS
RESULTS
Of the 684 enrolled symptomatic patients, 391 (57.7%) were female. The majority (87.7%) reported the presence of mosquito breeding sites within the household's compound, and fever was the most reported symptom (81.6%). The overall prevalence of the pfhrp2 gene deletion was 9.2% (95% CI: 6.7%-12.1%). The deletion of the pfhrp2 gene was associated with health zone of origin (P = 0.012) and age (P = 0.019). Among false-negative PfHRP2-RDT results, only 9.9% were due to pfhrp2 gene deletion.
CONCLUSIONS
CONCLUSIONS
P. falciparum isolates with pfhrp2 gene deletions are relatively common among symptomatic patients in Kwilu province. Further investigations are needed to provide enough evidence for policy change. Meanwhile, the use of RDTs targeting PfHRP2 and parasite lactate dehydrogenase (pLDH) antigens could limit the spread of deleted isolates.
Identifiants
pubmed: 34034827
doi: 10.1186/s40249-021-00860-1
pii: 10.1186/s40249-021-00860-1
pmc: PMC8146217
doi:
Substances chimiques
Antigens, Protozoan
0
Histidine
4QD397987E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
77Subventions
Organisme : Japan Society for the Promotion of Science
ID : 16K21233 and 19K07526
Références
Malar J. 2017 Mar 20;16(1):123
pubmed: 28320390
Elife. 2019 May 02;8:
pubmed: 31045490
Acta Trop. 2019 Aug;196:121-125
pubmed: 31103699
Am J Trop Med Hyg. 2012 Feb;86(2):194-8
pubmed: 22302847
Clin Microbiol Infect. 2019 May;25(5):580-585
pubmed: 30267926
Infect Genet Evol. 2017 Nov;55:131-134
pubmed: 28889944
PLoS One. 2017 Mar 16;12(3):e0171150
pubmed: 28301474
PLoS One. 2016 Aug 12;11(8):e0157949
pubmed: 27518538
J Infect Dis. 2017 Apr 1;215(7):1156-1166
pubmed: 28329034
J Infect Dis. 2018 Feb 14;217(5):685-692
pubmed: 29220497
Malar J. 2011 Mar 24;10:67
pubmed: 21435256
Acta Trop. 2013 Jan;125(1):119-21
pubmed: 23041541
PLoS One. 2012;7(8):e43094
pubmed: 22952633
Malar J. 2015 Oct 29;14:420
pubmed: 26511932
Sci Rep. 2017 Nov 7;7(1):14718
pubmed: 29116127
Malar J. 2018 Apr 2;17(1):137
pubmed: 29609602
Acta Trop. 2015 Dec;152:26-31
pubmed: 26297799
Malar J. 2018 Aug 31;17(1):320
pubmed: 30170596
PLoS One. 2015 May 15;10(5):e0126805
pubmed: 25978499
Malar J. 2013 Jan 24;12:34
pubmed: 23347727
PLoS One. 2016 Sep 16;11(9):e0163137
pubmed: 27636709
Med Sante Trop. 2013 May 1;23(2):181-4
pubmed: 23774584
Malar J. 2017 Nov 09;16(1):456
pubmed: 29121931
PLoS One. 2015 Jul 07;10(7):e0131576
pubmed: 26151448
Am J Trop Med Hyg. 2017 Oct;97(4):1155-1158
pubmed: 28820682
J Infect Dis. 2017 Jul 1;216(1):36-44
pubmed: 28177502
Am J Trop Med Hyg. 2019 Apr;100(4):842-845
pubmed: 30719965
Malar J. 2014 Jul 22;13:283
pubmed: 25052298
Malar J. 2017 Oct 16;16(1):416
pubmed: 29037193
Malar J. 2015 Jan 21;14:19
pubmed: 25604310
Elife. 2017 Oct 16;6:
pubmed: 29034876
Malar J. 2016 Feb 18;15:101
pubmed: 26891848
PLoS One. 2010 Jan 25;5(1):e8091
pubmed: 20111602
BMJ. 2004 Nov 20;329(7476):1212
pubmed: 15542534
Malar J. 2018 Oct 29;17(1):394
pubmed: 30373573
Sci Rep. 2013 Sep 30;3:2797
pubmed: 24077522
J Med Microbiol. 2013 Oct;62(Pt 10):1491-1505
pubmed: 24048274
Malar J. 2014 Jan 29;13:34
pubmed: 24472178